BeOne Medicines (ONC) Net Cash Flow Growth (5y) (2020 - 2026)
Powered by 
Analysis
BeOne Medicines (ONC) Net Cash Flow Growth (5y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.32% |
| Mar 31, 2026 | -15.61% |
| Dec 31, 2025 | 47.93% |
| Sep 30, 2025 | 63.89% |
| Jun 30, 2025 | 18.93% |
| Mar 31, 2025 | -15.81% |
| Dec 31, 2024 | 39.73% |
| Sep 30, 2024 | 35.45% |
| Jun 30, 2024 | -25.70% |
| Mar 31, 2024 | -59.13% |
| Dec 31, 2023 | 17.42% |
| Sep 30, 2023 | -27.53% |
| Jun 30, 2023 | -10.50% |
| Mar 31, 2023 | -26.91% |
| Dec 31, 2022 | -73.36% |
| Sep 30, 2022 | -37.68% |
| Jun 30, 2022 | 9.90% |
| Mar 31, 2022 | -41.20% |
| Dec 31, 2021 | 338.92% |
| Sep 30, 2021 | -75.23% |